全文获取类型
收费全文 | 106445篇 |
免费 | 6535篇 |
国内免费 | 451篇 |
专业分类
耳鼻咽喉 | 1239篇 |
儿科学 | 2761篇 |
妇产科学 | 1976篇 |
基础医学 | 13295篇 |
口腔科学 | 1826篇 |
临床医学 | 11126篇 |
内科学 | 21470篇 |
皮肤病学 | 1464篇 |
神经病学 | 10625篇 |
特种医学 | 4071篇 |
外国民族医学 | 3篇 |
外科学 | 17130篇 |
综合类 | 1180篇 |
一般理论 | 135篇 |
预防医学 | 8756篇 |
眼科学 | 2175篇 |
药学 | 6749篇 |
中国医学 | 105篇 |
肿瘤学 | 7345篇 |
出版年
2023年 | 578篇 |
2022年 | 964篇 |
2021年 | 2178篇 |
2020年 | 1370篇 |
2019年 | 2160篇 |
2018年 | 2622篇 |
2017年 | 1892篇 |
2016年 | 2057篇 |
2015年 | 2346篇 |
2014年 | 3551篇 |
2013年 | 4911篇 |
2012年 | 7796篇 |
2011年 | 8224篇 |
2010年 | 4713篇 |
2009年 | 4243篇 |
2008年 | 7350篇 |
2007年 | 7665篇 |
2006年 | 7388篇 |
2005年 | 7083篇 |
2004年 | 6909篇 |
2003年 | 6234篇 |
2002年 | 5887篇 |
2001年 | 1013篇 |
2000年 | 716篇 |
1999年 | 1069篇 |
1998年 | 1268篇 |
1997年 | 971篇 |
1996年 | 816篇 |
1995年 | 734篇 |
1994年 | 632篇 |
1993年 | 612篇 |
1992年 | 617篇 |
1991年 | 544篇 |
1990年 | 454篇 |
1989年 | 426篇 |
1988年 | 404篇 |
1987年 | 427篇 |
1986年 | 367篇 |
1985年 | 413篇 |
1984年 | 417篇 |
1983年 | 364篇 |
1982年 | 402篇 |
1981年 | 340篇 |
1980年 | 280篇 |
1979年 | 187篇 |
1978年 | 197篇 |
1977年 | 154篇 |
1976年 | 130篇 |
1974年 | 128篇 |
1973年 | 140篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
Zhenzhen Zhang Mark Garzotto Tomasz M. Beer Philippe Thuillier Stephen Lieberman Motomi Mori 《Nutrition and cancer》2016,68(8):1309-1319
Animal and human studies suggest fish oil and green tea may have protective effect on prostate cancer. Fatty acid synthase (FAS) has been hypothesized to be linked to chemoprotective effects of both compounds. This study evaluated the independent and joint effects of fish oil (FO) and green tea supplement (epigallocatechin-3-gallate, EGCG) on FAS and Ki-67 levels in prostate tissue. Through a double-blinded, randomized controlled trial with 2 × 2 factorial design, 89 men scheduled for repeat prostate biopsy following an initial negative prostate biopsy were randomized into either FO alone (1.9 g DHA + EPA/day), EGCG alone (600 mg/day), a combination of FO and EGCG, or placebo. We used linear mixed-effects models to test the differences of prostate tissue FAS and Ki-67 by immunohistochemistry between pre- and post-intervention within each group, as well as between treatment groups. Results did not show significant difference among treatment groups in pre-to-post-intervention changes of FAS (P = 0.69) or Ki-67 (P = 0.26). Comparing placebo group with any of the treatment groups, we did not find significant difference in FAS or Ki-67 changes (all P > 0.05). Results indicate FO or EGCG supplementation for a short duration may not be sufficient to produce biologically meaningful changes in FAS or Ki-67 levels in prostate tissue. 相似文献
2.
3.
4.
5.
6.
7.
Mark Verrill 《Surgery (Oxford)》2019,37(3):181-185
Multimodality primary therapies for breast cancer combined with earlier detection have led to a sharp decline in the death rate from breast cancer in the UK over the last 40 years in the face of a rising incidence. The latest UK statistics from Cancer Research UK report 55,122 new cases of breast cancer in 2015 with 11,563 deaths from breast cancer recorded in 2016. Crudely, this equates to a cure rate of around 80% for all comers and demonstrates a clear improvement in outcome with 50,285 new cases in 2011 and 11,716 deaths in 2012. Despite this good news, there are still significant numbers of women (and men) who suffer from either a local recurrence or metastatic disease following apparently successful treatment for early breast cancer (Stage I to III). Only a minority of individuals, 6.6% with the stage recorded at diagnosis, present with stage IV disease. This review considers the treatment options available to individuals with locally recurrent and advanced breast cancer (ABC). 相似文献
8.
Conall T. Morgan Brigitte Mueller Varsha Thakur Vitor Guerra Callaghan Jull Luc Mertens Mark Friedberg Fraser Golding Mike Seed Steven E.S. Miner Edgar T. Jaeggi Cedric Manlhiot Lynne E. Nield 《The Canadian journal of cardiology》2019,35(4):453-461
Background
The purpose of the study was to evaluate the association between fetal echocardiographic measurements and the need for intervention (primary coarctation repair, staged coarctation repair, or catheter intervention) in prenatally diagnosed coarctation of the aorta.Methods
A single-centre retrospective cohort study (2005-2015) of 107 fetuses diagnosed with suspected coarctation of the aorta in the setting of an apex-forming left ventricle and antegrade flow across the mitral and aortic valves.Results
Median gestational age at diagnosis was 32 weeks (interquartile range, 23-35 weeks). Fifty-six (52%) did not require any neonatal intervention, 51 patients (48%) underwent a biventricular repair. In univariable analysis, an increase in ascending aorta (AAo) peak Doppler flow velocity (odds ratio [OR], 1.40 [95% confidence interval [CI], 1.05-1.91] per 20 cm/s; P = 0.03) was associated with intervention. No intervention was associated with larger isthmus size (OR, 0.23; P < 0.001), transverse arch diameter (OR, 0.23; P < 0.001), and aortic (OR, 0.72; P = 0.02), mitral (OR, 0.58; P = 0.001), and AAo (OR, 0.53; P < 0.001) z-scores. In multivariable analysis, higher peak AAo Doppler (OR, 2.51 [95% CI, 1.54-4.58] per 20 cm/s; P = 0.001) and younger gestational age at diagnosis (OR, 0.81 [95% CI, 0.70-0.93] per week; P = 0.005) were associated with intervention, whereas a higher AAo z-score (OR, 0.65 [95% CI, 0.43-0.94] per z; P = 0.029) and transverse arch dimension (OR, 0.44 [95% CI, 0.18-0.97]; P = 0.05) decreased the risk of intervention.Conclusions
In prenatally suspected coarctation, the variables associated with intervention comprised smaller AAo and transverse arch size, earlier gestational age at diagnosis, and the additional finding of a higher peak AAo Doppler. 相似文献9.
10.
Stress Testing Versus CT Angiography in Patients With Diabetes and Suspected Coronary Artery Disease
Abhinav Sharma Adrian Coles Nishant K. Sekaran Neha J. Pagidipati Michael T. Lu Daniel B. Mark Kerry L. Lee Hussein R. Al-Khalidi Udo Hoffmann Pamela S. Douglas 《Journal of the American College of Cardiology》2019,73(8):893-902